Platelet Aggregation Inhibitors [inhibitory agregace trombocytů]
- Terms
-
antagonisté PAR-1
antagonisté proteázou aktivovaného receptoru PAR-1
antiagregační látky
antiagregancia
antitrombotické látky
antitrombotika
inhibitor agregace krevních destiček
inhibitory agregace krevních destiček
protidestičkové léky
trombocyty - inhibitory agregace
-
Antiaggregants, Platelet
Antiplatelet Agent
Antiplatelet Agents
Antiplatelet Drug
Antiplatelet Drugs
Blood Platelet Aggregation Inhibitor
Blood Platelet Aggregation Inhibitors
Blood Platelet Antagonist
Blood Platelet Antagonists
Blood Platelet Antiaggregant
Blood Platelet Antiaggregants
PAR-1 Antagonists
Platelet Aggregation Inhibitor
Platelet Antagonist
Platelet Antagonists
Platelet Antiaggregant
Platelet Antiaggregants
Platelet Inhibitor
Platelet Inhibitors
Protease-Activated Receptor-1 Antagonists
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
- DUI
- D010975 MeSH Browser
- CUI
- M0017012
- Previous indexing
- Blood Platelets (1966-1987); Platelet Adhesiveness (1972-1987); Platelet Aggregation (1976-1987)
- History note
- 88
- Public note
- 88
Allowable subheadings
- AD
- administration & dosage 344
- AE
- adverse effects 248
- AG
- agonists
- AN
- analysis 2
- BL
- blood 12
- CF
- cerebrospinal fluid
- CS
- chemical synthesis 3
- CH
- chemistry 15
- CL
- classification 60
- EC
- economics 5
- HI
- history 1
- IM
- immunology 2
- IP
- isolation & purification 1
- ME
- metabolism 9
- PK
- pharmacokinetics 46
- PD
- pharmacology 261
- PO
- poisoning
- RE
- radiation effects
- ST
- standards 7
- SD
- supply & distribution
- TU
- therapeutic use 847
- TO
- toxicity 1
- UR
- urine